Dr. Hanrahan is the Chief Regulatory Officer and leads regulatory engagement across all Solid programs.
Dr. Hanrahan joined Solid Biosciences as Chief Regulatory Officer in 2022. She brings nearly two decades of biotechnology industry experience to Solid where she will set and oversee regulatory strategy for the company as they seek to advance gene therapies for rare debilitating diseases into the clinic.
Previously, she was Chief Regulatory Officer of AavantiBio, a gene therapy company, where she served as a member of the executive leadership team and guided the regulatory and development strategy for the company. Before that, Jessie was Vice President of Regulatory Science at bluebird bio, where her achievements included obtaining numerous global regulatory designations from the FDA and EMA. Jessie also played a critical role in the MAA submission and approval of Zynteglo and the MAA submission for eli-cel which was later approved. Earlier in her career, she worked at Sanofi Genzyme and contributed to multinational approvals of Mozobil (US, EU, Canada, Australia, and many other regions) and Lemtrada (US, EU, and Canada). Jessie engages in key fieldwide initiatives, including the Accelerator Forum and ARM’s Executive Women’s Group.
Dr. Hanrahan holds a PhD in biology, as well as an MS and MPH, from Yale University and obtained her BA from Mount Holyoke College.
What is Jessie Hanrahan's net worth?
The estimated net worth of Jessie Hanrahan is at least $522.46 thousand as of February 18th, 2026. Dr. Hanrahan owns 74,318 shares of Solid Biosciences stock worth more than $522,456 as of March 21st. This net worth approximation does not reflect any other investments that Dr. Hanrahan may own. Learn More about Jessie Hanrahan's net worth.
How old is Jessie Hanrahan?
Dr. Hanrahan is currently 48 years old. There are 4 older executives and 3 younger executives at Solid Biosciences. The oldest executive at Solid Biosciences is Mr. Ian F. Smith A.C.A., C.P.A., Executive Chair, who is 58 years old. Learn More on Jessie Hanrahan's age.
How do I contact Jessie Hanrahan?
Has Jessie Hanrahan been buying or selling shares of Solid Biosciences?
During the last quarter, Jessie Hanrahan has sold $445,351.80 in Solid Biosciences stock. Most recently, Jessie Hanrahan sold 4,134 shares of the business's stock in a transaction on Wednesday, February 18th. The shares were sold at an average price of $5.82, for a transaction totalling $24,059.88. Following the completion of the sale, the insider now directly owns 74,318 shares of the company's stock, valued at $432,530.76. Learn More on Jessie Hanrahan's trading history.
Who are Solid Biosciences' active insiders?
Are insiders buying or selling shares of Solid Biosciences?
During the last twelve months, insiders at the sold shares 32 times. They sold a total of 623,491 shares worth more than $3,950,941.46. The most recent insider tranaction occured on February, 18th when CFO Kevin Tan sold 5,404 shares worth more than $31,451.28. Insiders at Solid Biosciences own 1.9% of the company.
Learn More about insider trades at Solid Biosciences. Information on this page was last updated on 2/18/2026.
